Sangui BioTech International Inc (SGBI) – Company Profile and SWOT Analysis

Sangui BioTech International Inc (SGBI) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sangui BioTech International Inc (SGBI) is a holding company that secures financing and capital market access, with operations managed through its subsidiary, Sangui BioTech GmbH. The company develops innovative oxygen supply technologies for medical and cosmetic applications, including wound management products, artificial oxygen carriers, and blood substitutes. These technologies are licensed to industry partners in exchange for royalties. Sangui BioTech GmbH's lead product, Granulox, is a hemoglobin spray that improves chronic wound healing by providing oxygen. Its PEGylated hemoglobin hyperpolymers serve as a blood additive, enhancing oxygen transport to treat conditions like heart attacks, strokes, and cancer. SGBI is headquartered in Hamburg, Germany.

Scope

• Detailed information on Sangui BioTech International Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Sangui BioTech International Inc in the form of a SWOT analysis

• An in-depth view of the business model of Sangui BioTech International Inc including a breakdown and examination of key business segments

• News about Sangui BioTech International Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Sangui BioTech International Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Sangui BioTech International Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Johnson & Johnson

Coloplast A/S

Bristol-Myers Squibb Co

Sanara MedTech Inc

Table of Contents